Company intelligence / Profile preview

Immunsystem

Uppsala, Sweden

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Immunsystem is a Swedish biotechnology company specializing in the development and production of avian antibodies (IgY) for research and diagnostic applications. Founded in 1981 and based in Uppsala, the company leverages the unique advantages of egg yolk-derived antibodies, which offer high specificity and reduced cross-reactivity compared to mammalian antibodies. Immunsystem provides custom antibody production services, purification, and a range of catalog antibodies and diagnostic kits. Their expertise extends to the development of point-of-care tests and specialized reagents for the life science community. The company is recognized as a pioneer in the commercialization of IgY technology.

Therapeutic areas: Other
Modalities: Antibody
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Immunsystem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunsystem.

Explore the full profile